of course Buffett isn't going to say anything meaningfully negative -- wouldn't that be a conflict of interest if he did (in view of his huge investment in BAC)? How naïve (or not too bright) can anyone be to expect anyone to incriminate a very large financial holding...period.
In other words, the shareholders (and the public which bailed this too-big-to-fail out) got screwed...again. Sick of this.
...and further warns it could reduce further:
" For Bank of America, analysts are reducing estimates on lower capital deployment and trading. The second-quarter EPS estimate was lowered to 30 cents from 33 cents. Full year estimates were reduced to 90 cents from $1.00 to reflect lower fixed-income and equity revenues throughout the year in addition to less capital deployment over the next few quarters than previously forecast. Analysts reduced the 2015 EPS estimates to $1.50 from $1.55. The new revisions for Bank of America were subject to further adjustment pending feedback from the Fed on the company's resubmitted stress test, noted the analysts. Analysts project the bank will repurchase just under $2 billion of share in the next year compared to previous estimates of $4 billion shares. KBW said they were more concerned about future litigation costs than share buybacks effecting the bank's profitability." See Marketplace PR just released.
The update was prromised about 5 months ago, and there's still no update, but instead, there is an "update" on a SINGLE patient in a very early study of the drug? Are you kidding me? Linda, IMHO you need to post results from the study you promised on the Glio study which is overdue by many months -- instead of trying to divert attention to the single result you published on the very pre-mature study of 1 single patient which you released on 5/15th -- yet haven't issued results of what you promised months ago: are you trying to change the subject? Shame on you for using a single patient's results (and at such a premature phase) instead of releasing the data you should have released months ago. Shame on you for using and abusing cancer patients!!!!!!! IMHO
you mean to find another manipulative of cancer patients PR? Where's the PR due on the Glioblastoma study which was promised many many months ago?
manipulators (representing whom you ask??????????) trying to bury this FACT: FACT is the promised update from months ago has not been issued and it appears (to some of us) that this company is attempting to divert attention to premature results (which are highly questionable to begin with) about 1 single patient (maybe they'll update it to include a couple more) in a very very very early study. This company is odious to me and I am entitled to my opinion which is based upon the FACT that the promised Glioblastoma results for this co's drug have NOT BEEN RELEASED.
you have absolutely no clue because it never takes "the board" so many months to report. who are you kidding?
what a stupid ad hominem -- whats the matter, out of factual ammunition? Here is the fact: NWBO has not released the study results it promised about 5 months ago -- this is odious and does not portend anything positive. Instead, the company is trying to change the subject by releasing the results of a single individual's results (which are highly questionable to begin with) in a study which is so premature and early, it shouldn't even be on anyone's radar -- but plug on, eventually fact will catch up with the misrepresentations, lies, etc. going around here..
"The DSMB's review of the efficacy data is still pending." Don't confuse this with that 1-person (alleged) data they made a big broo-ha-ha about in a release on 5/15 -- where are the glioma results promised months ago??? This statement was made in NWBO's press release dated March 7, 2014. To-date, no efficacy data has been released by NWBO.
the share price may be low because the company still hasn't released the promised results of many months ago
"the Data Safety Monitoring Board (DSMB) has made an unblinded review of the safety data for the Company's ongoing international Phase III GBM Trial, and has recommended that the trial continue as planned." HOWEVER, "
"The DSMB's review of the efficacy data is still pending." This was as of the company's PR back in March 2014...and still no results have been released about the efficacy.
if there was ANYTHING honest, i.e., not snake oil hopium being sold on this board by paid touts and others, the results of the Glioma trial would have already been released, and the results of a very very early preliminary whatever trial on 1 single individual would not have been the source of a press release for any serious and honest company. This is my opinion: don't like it, then show me reliable, honest results by independent review and analysis on the Glio study -- otherwise, well, you know. How about your alleged 45,000 share that you claim to have in the post that has been deleted here on Yahoo ?
You are a paid tout IMHO.
But sentiment: where's the independently reviewed data on the Glio that was promised months ago? How can anyone reasonably believe any new case study of anything when so far the co has not delivered on releasing the independently reviewed data that was promised by the co months ago? Are they trying to change the subject? Are you?
obviously turtle can't refute there is an issue with months overdue non-released material data by this company (which raises big wavy red flags), so, turtle (and other paid touts) can do nothing other than issue empty ad hominem attacks because they have absolutely nothing material to say.